| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 04/11/2006 | US7026505 Method of treating tinnitus |
| 04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
| 04/11/2006 | US7026498 Coordination catalyst containing ligand |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026481 Reacting 1,4-dialkylcarboxylate-2,5-bis(N-arylamino)benzene with iodoaryl compound |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/06/2006 | WO2006035678A1 Diagnostic agent for tumor |
| 04/06/2006 | WO2006035080A1 Method of obtaining cyclic amino acids |
| 04/06/2006 | WO2006017455A3 Diastereoselective reductive amination process |
| 04/06/2006 | US20060074259 Process for the enzymatic synthesis of pyroglutamic esters |
| 04/06/2006 | US20060074249 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes |
| 04/06/2006 | US20060074074 Reacting compounds such as 5-(3,4-dimethoxybenzoyl)-2-(1-isopropoxycarbonyloxy-2-methylpropyl)-2-1,2,3-triazole-4-carboxylate with carbonyl compounds, reacting with an alcohol to produce 1-(1-Isopropoxycarbonyloxyethyl)-7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzazepine |
| 04/06/2006 | US20060070953 Process for the recovery of tyrosol and hydroxytyrosol from oil mill wastewaters and catalytic oxidation method in order to convert tyrosol in hydroxytyrosol |
| 04/06/2006 | CA2581204A1 Aminolevulinic acid compounds for diagnosing tumors |
| 04/05/2006 | EP1642885A1 Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract |
| 04/05/2006 | EP1642883A2 Optically active cyclohexylphenylglycolate esters |
| 04/05/2006 | EP1641742A2 Compounds that selectively bind to membranes of apoptotic cells |
| 04/05/2006 | EP1641741A1 Levalbuterol hydrochloride polymorph b |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP0897747B1 Nitration or carboxylation catalysts |
| 04/05/2006 | CN1756734A Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
| 04/04/2006 | US7022875 Thiobutacin and antifungal and antioomycete composition for controlling plant diseases using the same |
| 04/04/2006 | US7022872 comprises intermediates such as 2-tert-butoxycarbonylamino-3-(2-fluoro-4,5-dimethoxy-phenyl)-acrylic acid ethyl ester; olefin intermediate can be stereoselectively hydrogenated to produce the R or S enantiomer |
| 04/04/2006 | US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 04/04/2006 | US7022310 Deuterated hydrogen in protein, radioactive carbon or nitrogen; bioassay of accurate analyzing the structure of the target high molecular weight protein; producing stable isotope-labeled fumaric acid, tartaric acid through esterification, oxidation, hydrolysis; chemical peptide synthesis |
| 04/04/2006 | US7021697 Vehicle and a vehicle door |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 03/30/2006 | WO2006033714A2 Metal chelators and methods of their use |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 03/30/2006 | US20060069058 Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide |
| 03/30/2006 | US20060067903 Using 2-difluoromethylornithine |
| 03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 03/29/2006 | CN1752070A Synthesis method of valine crystallizing agent |
| 03/29/2006 | CN1752068A Synthesis method of kynureninase specificity inhibitor-L-methoxybenzoyl alanine |
| 03/29/2006 | CN1247527C 6-fluorobicyclo [3.1.0] hexame derivatives |
| 03/29/2006 | CN1247526C Diaminodicarboxylic acid and its intermediate |
| 03/29/2006 | CN1247525C Process for preparing N-(substituted phenyl) alanine and its ester and racemization method of its optical configuration body |
| 03/29/2006 | CN1247524C Process for separating betaine from water solution of betaine chemically synthetic reaction product |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/28/2006 | US7019161 Processes for the preparation of 3-aminocarboxylic acids and their esters |
| 03/28/2006 | US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders |
| 03/28/2006 | US7019104 Diamine novel acid dianhydride and novel polyimide composition formed therefrom |
| 03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
| 03/28/2006 | US7019045 Amino group containing phenol |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | US7018599 Fullerene derivatives |
| 03/23/2006 | WO2006030208A1 Amino acid |
| 03/23/2006 | DE102004036787A1 Verfahren zur Herstellung von alkylierten Aminen A process for the preparation of alkylated amines |
| 03/22/2006 | EP1636163A1 Process for the preparation of gabapentin |
| 03/22/2006 | EP1192119B1 Process for the preparation of 3,3-dimethylbutanal |
| 03/22/2006 | EP1020426B9 Amine derivatives and process for producing the same |
| 03/22/2006 | CN1751034A Process for the preparation of bicyclic aromatic amino acids and intermediates thereof |
| 03/22/2006 | CN1749237A Tetra substituted chalcone derivative and preparing method and use |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/22/2006 | CN1246295C Method and intermediate used for manufacturing antifolic |
| 03/22/2006 | CN1245936C Detergent composition containing new glycine derivative and its use |
| 03/21/2006 | US7015352 Capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced |
| 03/21/2006 | US7015349 A conjugate of alpha -difluoromethylornithine can be applied topically to reduce hair growth from the area of skin in on the face, legs or underarm |
| 03/21/2006 | US7015348 By means of catalytic and asymmetric synthesis method of high performance and high enantiomeric excess, which comprises subjecting an enamine to an asymmetric hydrogenation |
| 03/21/2006 | US7015346 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015019 1-O-L-arginyl ester 3-O-monoacyl glycerides and 1-O-L-arginyl ester 2,3-O-diacyl glycerides type surface active agents |
| 03/21/2006 | CA2267251C Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 03/21/2006 | CA2245647C Novel bridged cyclic amino acids as pharmaceutical agents |
| 03/21/2006 | CA2190577C Enantioselective preparation of optically pure albuterol |
| 03/16/2006 | WO2006028068A1 Methods of purifying l-carnitine |
| 03/16/2006 | WO2006026876A1 Anti-bacterial compounds |
| 03/16/2006 | US20060058391 Calcium receptor antagonist; (E)-3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-acrylic acid hydrochloride; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, arthritis, Paget's disease, humoral hypercalcemia, osteoporosis |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/16/2006 | DE102004035978A1 New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis |
| 03/16/2006 | DE102004035808A1 Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen Ammonium salts and ammonium salt Mineralsalzchlatrate as transport and active form for pharmaceutical and medical-phase transfer agent for chemical applications |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1633190A1 Copper salts of organic acids and use thereof as fungicides |
| 03/15/2006 | CN1245379C Method for preparing gabapentin |
| 03/15/2006 | CN1245378C Process for preparing [F]fluoro-L-dopa |
| 03/14/2006 | US7012158 Providing an intermediate compound having fluorine and a nitrile groups; selectively reducing nitrile group to form an amine group, further hydrolyzing the intermediate compound produced |
| 03/14/2006 | US7012152 Reduction of 2-amino-6-methyl-6-nitroheptanoic acid |
| 03/14/2006 | US7012151 the highly regioselective aromatic nitration of alkyl 4-alkanoylamino-3-alkyl-benzoates in the 5-position in a mixture containing nitric acid |
| 03/14/2006 | CA2180963C Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-.beta.-amino acids |
| 03/14/2006 | CA2147984C Butenyl-substituted taxanes and composition |
| 03/14/2006 | CA2125223C Control of scale formation and corrosion in aqueous systems |
| 03/09/2006 | WO2006024784A2 Aminoglycoside analogues, uses thereof for treating microbial diseases and synthesis thereof |
| 03/09/2006 | WO2006024436A1 Process for the preparation of 4,5-diamino shikimicacid |
| 03/09/2006 | US20060052627 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/09/2006 | CA2577192A1 Process for the preparation of 4,5-diamino shikimic acid |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1385821A4 Novel anti-adhesive compounds and uses thereof |
| 03/08/2006 | EP1335904B1 Production of alkyl 6-aminocaproate |
| 03/08/2006 | CN1745061A Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
| 03/08/2006 | CN1743306A Imido diacetate environment-protection clean production method |
| 03/08/2006 | CN1244547C Preparation method of N-(1-S-ethoxycarbonyl-3-phenyl propyl)-S-alanine |
| 03/08/2006 | CN1244546C Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate |